Trial NCT04785547

View at ClinicalTrials.gov 
Org. Study IDs: FORUM Add-on Blina post TX

Last trial update was posted on 2024-01-16

MeSH Interventions

Blinatumomab

MeSH Conditions

Neoplasm, Residual Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

ALL, Childhood Minimal Residual Disease

Stopping Reasons

Terminated by Amgen Limited

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID